Intrauterine growth retardation alters mitochondrial gene expression and function in fetal and juvenile rat skeletal muscle.
Uteroplacental insufficiency alters the anabolic metabolism of the fetus, resulting in intrauterine growth retardation (IUGR). The metabolic and physiologic factors that cause IUGR have long standing consequences after birth. Postnatal growth and glucose metabolism are altered in the IUGR infant. Skeletal muscle is an important component of growth and metabolizes up to 70% of i.v. glucose. The ability of skeletal muscle to metabolize glucose is affected by ATP availability. We hypothesized that gene expression and function of proteins involved in mitochondrial ATP production and distribution would be altered in juvenile IUGR muscle. To test this hypothesis, we used a model of IUGR, induced by bilateral uterine artery ligation in the pregnant rat, that mimics uteroplacental insufficiency in the human. RT-PCR was used to measure the mRNA levels of three important mitochondrial proteins; NADH-ubiquinone-oxireductase subunit 4L(ND-4L), subunit C of the F1F0-ATP synthase (SUC), and adenine nucleotide translocator 1 (ANT1) in IUGR and control rats in fetal and juvenile life. In the fetus, mRNA levels of all three proteins were significantly increased in IUGR skeletal muscle. In contrast, in juvenile animals, mRNA levels of all three proteins were significantly decreased. mRNA levels of other metabolically important proteins, glucose-6-phosphate dehydrogenase and carnitine-palmitoyl-transferase II, were not significantly altered in IUGR juvenile animals. To assess if decreased gene expression is associated with altered mitochondrial function, we measured the mitochondrial NAD+/NADH ratio in d 21 juvenile control and IUGR muscle. At d 21, decreased gene expression if ND-4L, SUC, and ANTI is associated with a decreased mitochondrial NAD+/NADH ratio. The results of our study suggest that the metabolic alterations associated with uteroplacental insufficiency in the rat result in altered fetal and postnatal muscle mitochondrial mRNA expression as well as altered postnatal mitochondrial function.
Lane
R H
RH
Department of Pediatrics, University of Pittsburgh School of Medicine, Magee-Women's Research Institute, Pennsylvania 15213, USA.
Chandorkar
A K
AK
Flozak
A S
AS
Simmons
R A
RA
D000818:Animals; D002334:Carnitine O-Palmitoyltransferase / Q000096:biosynthesis; D042967:Electron Transport Complex I; D005260:Female; D005317:Fetal Growth Retardation / Q000196:embryology / Q000378:metabolism* / Q000503:physiopathology; D018507:Gene Expression Regulation, Developmental; D005954:Glucosephosphate Dehydrogenase / Q000096:biosynthesis; D006801:Humans; D008931:Mitochondria, Muscle / Q000378:metabolism*; D000226:Mitochondrial ADP, ATP Translocases / Q000096:biosynthesis; D024510:Muscle Development; D018482:Muscle, Skeletal / Q000196:embryology / Q000254:growth & development / Q000378:metabolism*; D009243:NAD / Q000378:metabolism; D009247:NADH, NADPH Oxidoreductases / Q000096:biosynthesis; D010084:Oxidation-Reduction; D010920:Placenta / Q000502:physiology / Q000503:physiopathology; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D006180:Proton-Translocating ATPases / Q000096:biosynthesis; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D014158:Transcription, Genetic; D014599:Uterus / Q000502:physiology / Q000503:physiopathology
D012333:RNA, Messenger; D009243:NAD; D000226:Mitochondrial ADP, ATP Translocases; D005954:Glucosephosphate Dehydrogenase; D009247:NADH, NADPH Oxidoreductases; D002334:Carnitine O-Palmitoyltransferase; D006180:Proton-Translocating ATPases; D042967:Electron Transport Complex I